MedTrace Logo

Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

NCT03302559 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2019-06-04

Study results available
· View outcomes & findings →

Summary

This study will assess the cosmetic changes of a cosmetic topical retinoid product in participants with moderate to severe photodamage utilizing non-invasive in vivo skin imaging instrumentation.

Conditions

  • Skin Care

Interventions

OTHER

Retinol Complex 0.5

Retinol Complex 0.5 topically in the evening.

OTHER

Facial cleanser

Facial cleanser in the morning and in the evening.

OTHER

Moisturizing lotion

Fragrance free moisturizing lotion in the morning and in the evening.

OTHER

Sunscreen

Sunscreen broad spectrum sun protection factor (SPF) 35 topically in the morning and as needed.

DEVICE

Skin Imaging

Non-invasive in vivo skin imaging will be taken with the VivoSight Dx Optical Coherence Tomography (OCT) and VivaScope 1500

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Lisa Goberdhan, B.A. · Allergan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-18
Primary Completion
2018-04-30
Completion
2018-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03302559 on ClinicalTrials.gov